News

12 Feb 2021

TRIG acquires the Grönhult onshore wind farm in Sweden

The Renewables Infrastructure Group (TRIG) has announced that it has acquired the Grönhult onshore wind farm in Sweden. Grönhult is a 67.2 MW ready-to-build onshore wind farm located in the southwest of Sweden. The Grönhult project is being acquired from Vattenfall, the leading Swedish utility and a major developer of renewables, who will also manage the […]

12 Feb 2021

Apax Global Alpha – Apax X acquiring majority stake in Herjavec Group

Apax Global Alpha (AGA) has announced that, on 11 February 2021, the Apax X Fund, in which AGA is a limited partner, announced that it has entered into a definitive agreement to acquire a majority stake of Herjavec Group (HG), a global Managed Security Services Provider (MSSP) and cyber operations leader. The transaction is expected […]

12 Feb 2021

QuotedData’s morning briefing 12 February 2021

In QuotedData’s morning briefing 12 February 2021 Tetragon Financial are holding an investor call on 26 February 2021 at 3pm (UK time) to discuss its annual report and to provide a company update. The audio conference call may be accessed by dialling +44 (0) 800 358 9473 in the United Kingdom and +1 855 857 0686 […]

05 Feb 2021

Warehouse REIT announces fundraise and Harlow acquisition

Warehouse REIT (WHR) has, in two separate releases, announced the acquisition of two adjacent distribution warehouses in Harlow as well as a fundraise that aims to raise gross proceeds of up to £45.9 million. The two warehouses total 177,000 sq ft and were purchased for £13.9 million including costs. The combined property generates £1.2 million […]

05 Feb 2021

Syncona’s Achilles Therapeutics announces positive trial recommendation

Achilles Therapeutics, a Syncona portfolio company, has announced that an Independent Data and Safety Monitoring Committee (IDSMC) has completed its first review of the ongoing, first-in-human Phase I/II CHIRON and THETIS trials and has recommended that both clinical trials continue as planned. Achilles Therapeutics is a clinical-stage biopharmaceutical company developing precision T cell therapies to […]

05 Feb 2021

Successful IPO for RTW Venture Fund’s Landos Biopharma

RTW Venture Fund has provided a brief update on portfolio company Landos Biopharma’s IPO. The IPO raised US$100 million by offering 6,250,000 shares at $16.00 per share, and Landos is now listed on the Nasdaq Global Market under ticker: LABP. Landos was one of the seed assets included in the Company’s portfolio at the time of […]

05 Feb 2021

BlackRock Energy and Resources Income making progress on transition

BlackRock Energy and Resources Income (BERI) has announced its annual results for the year ended 30 November 2020 which show that the trust is making progress on its transition to stocks that offer exposure to the transition in the energy sector, away from carbon-based energy supplies towards alternative and renewable sources. The implementation of this […]

05 Feb 2021

QuotedData’s morning briefing 5 February 2021

In QuotedData’s morning briefing 5 February 2021: Capital & Counties has announced the appointment of Jefferies International Limited as joint corporate broker, alongside the Company’s existing corporate broker UBS AG London Branch, with immediate effect. It has also announced that UBS South Africa (Pty) Limited has been appointed as its sole JSE Sponsor, with effect from […]

29 Jan 2021

FDA delay backs BB Biotech view on Biogen Alzheimer’s drug

US biotech giant Biogen – in which the Swiss investor BB Biotech (SIX:BION) holds a stake equivalent to 2.9% of its portfolio value – has seen its stock open up 7% this morning on the back of announcement by the FDA of a three-month delay in the review of the controversial Alzheimer’s therapy aducanumab. The […]